The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration ... The drug is initiated with ...

Researchers found that metformin, a diabetes medication, may reduce the risk of age-related macular degeneration (AMD). Their ...

Age-related macular degeneration (AMD ... some researchers have turned their attention to metformin—a drug better known for treating type 2 diabetes—because of promising data on its overall ...

SOL-1 is now expected to be enrolled and fully randomized by year-end 2024Topline clinical data from SOL-1 are now expected in Q4 2025BEDFORD, ...

Ocugen (OCGN) reported that the FDA has lifted the clinical hold on the investigational new drug application for the Phase 1 clinical ...

Vabysmo (faricimab-svoa) is a brand-name injection prescribed for certain eye conditions, including wet age-related macular degeneration. The cost of the drug with and without insurance can depend ...

BenevolentAI and a group of UK sight loss charities have launched a new partnership ... AI-powered drug discovery to find treatments and a potential cure for age-related macular degeneration ...

The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust ...

The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...